Transcure Bioservices

TransCure bioServices is a contract research organisation that runs preclinical studies in humanized and conventional mouse models. Its model range includes human immune system (CD34+) mice, humanized liver mice, double humanized mice and standard immunodeficient and immunocompetent mice. Study services cover oncology (human CDX and PDX tumour models, syngeneic models), inflammation (IBD, MASH, GvHD, lung inflammation) and infectious disease and toxicity (HIV, HBV, hepatotoxicity, immunotoxicity).

The company works with research and development teams that assess the efficacy and toxicity of lead drug candidates in these models. It describes its approach as flexible, with study protocols adapted based on real-time data, and it is AAALAC accredited. The company has published posters on its models, including work on luciferase-expressing AML cell lines.

TransCure bioServices was founded in 2012 and is headquartered in Archamps, France. The website states that it has 70 collaborators and 12 years of experience with validated mouse models.

Product: Preclinical study services using humanized and conventional mouse models, including CDX/PDX oncology, inflammation, infectious disease and toxicity models.